Tenax Therapeutics Ownership | Who Owns Tenax Therapeutics?

Tenax Therapeutics Ownership Summary

Tenax Therapeutics is owned by 1.31% institutional investors, and 98.69% retail investors. T. Rowe Price Health Sciences is the top mutual fund, with 0.62% of its assets in Tenax Therapeutics shares.

TENX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tenax Therapeutics	1.31%	-	98.69%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2022	15	-25.00%	2,428,685	-66.66%	1	8.51%	6	-50.00%	4	300.00%
Sep 30, 2022	20	33.33%	7,283,589	5.12%	3	28.22%	12	140.00%	1	-66.67%
Jun 30, 2022	15	-	6,928,902	-14.27%	3	19.73%	5	66.67%	3	-25.00%
Mar 31, 2022	15	-6.25%	8,082,294	0.25%	4	23.13%	3	-57.14%	4	100.00%
Dec 31, 2021	16	14.29%	8,062,390	4.55%	4	25.22%	7	16.67%	2	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
T. Rowe Price Health Sciences	21.18K	0.62%	-89.13K
DFA US Targeted Value I	18.47K	0.54%	5.65K
Fidelity Extended Market Index	10.45K	0.31%	-42.00
T. Rowe Price Health Sciences Port	5.36K	0.16%	5.36K
Fidelity Series Total Market Index	4.48K	0.13%	4.48K
Spartan Extended Market Index Pool E	2.81K	0.08%	2.81K
Dimensional US Sustainability Core 1 ETF	2.54K	0.07%	-
Vanguard Institutional Extnd Mkt Idx Tr	2.33K	0.07%	-
Fidelity Nasdaq Composite Index	384.00	0.01%	-
Spartan Total Market Index Pool E	265.00	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 08, 2024	PROEHL GERALD T	-	Buy	$316.54
Aug 08, 2024	PROEHL GERALD T	-	Buy	$5.00K
Aug 08, 2024	PROEHL GERALD T	-	Buy	$74.97K
Aug 08, 2024	Davidson Michael H.	-	Buy	$475.00
Aug 08, 2024	Davidson Michael H.	-	Buy	$112.50K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	6	-
2024 Q2	-	-
2024 Q1	-	-
2022 Q3	-	-
2022 Q2	-	-

TENX Ownership FAQ

Who Owns Tenax Therapeutics?

Tenax Therapeutics shareholders are primarily institutional investors at 1.31%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Tenax Therapeutics's industry, Biotech Stocks , is 44.97%, which Tenax Therapeutics falls below.

Does Blackrock own Tenax Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tenax Therapeutics.

Who is the top mutual fund holder of Tenax Therapeutics shares?

T. Rowe Price Health Sciences is the top mutual fund holder of Tenax Therapeutics shares, with 0.62% of its total shares outstanding invested in 21.18K Tenax Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools